Graceptor®
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
the Maintenance Phase After Kidney Transplantation
Conditions
the Maintenance Phase After Kidney Transplantation
Trial Timeline
Nov 15, 2013 → Mar 31, 2016
NCT ID
NCT02160054About Graceptor®
Graceptor® is a pre-clinical stage product being developed by Astellas Pharma for the Maintenance Phase After Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT02160054. Target conditions include the Maintenance Phase After Kidney Transplantation.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02160054 | Pre-clinical | Completed |
Competing Products
20 competing products in the Maintenance Phase After Kidney Transplantation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| LY2422347 + placebo | Eli Lilly | Phase 2 | 52 |
| LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - Capsule | Eli Lilly | Phase 1 | 33 |
| Zolpidem MR + Estazolam | Astellas Pharma | Approved | 85 |
| zolpidem MR + nitrazepam + placebo | Astellas Pharma | Phase 3 | 77 |
| FK199B + Zolpidem | Astellas Pharma | Phase 3 | 77 |
| ASP7991 | Astellas Pharma | Phase 1 | 33 |
| Zolpidem MR + Zolpidem IR | Astellas Pharma | Approved | 85 |
| Zolpidem MR + Zolpidem | Astellas Pharma | Phase 3 | 77 |
| Lemborexant | Eisai | Phase 2 | 52 |
| Lemborexant + Placebo | Eisai | Phase 3 | 77 |
| Lemborexant | Eisai | Pre-clinical | 23 |
| Eszopiclone + Fluoxetine + Placebo | Sumitomo Pharma | Approved | 85 |
| Org 50081 + Org 50081 + Placebo + zopiclone | Merck | Phase 1 | 33 |
| esmirtazapine | Merck | Phase 3 | 77 |
| Esmirtazapine | Merck | Phase 3 | 77 |
| Suvorexant + Placebo | Merck | Phase 3 | 77 |
| Esmirtazapine + Placebo | Merck | Phase 3 | 77 |
| Enteric-coated Mycophenolate sodium (EC-MPS) + Mycophenolate mofetil | Novartis | Approved | 85 |
| Cyclosporine - cyclosporine microemulsion | Novartis | Approved | 85 |
| Enteric-coated Mycophenolate sodium (EC-MPS) | Novartis | Approved | 85 |